A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

NCT01288911 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

375

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: enzalutamide
DRUG: bicalutamide

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]